232 related articles for article (PubMed ID: 25980823)
1. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
2. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y
PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207
[TBL] [Abstract][Full Text] [Related]
3. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
[TBL] [Abstract][Full Text] [Related]
4. Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo.
Li Y; Jiang F; Chen L; Yang Y; Cao S; Ye Y; Wang X; Mu J; Li Z; Li L
FEBS Open Bio; 2015; 5():466-75. PubMed ID: 26106521
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
6. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
7. Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.
Ye X; Jiang F; Li Y; Mu J; Si L; Wang X; Ning S; Li Z
Cancer Sci; 2014 Jul; 105(7):875-82. PubMed ID: 24754877
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
11. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
12. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells.
Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J
Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).
Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C
Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
15. Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway.
Hsu YL; Wu LY; Hou MF; Tsai EM; Lee JN; Liang HL; Jong YJ; Hung CH; Kuo PL
Mol Nutr Food Res; 2011 Feb; 55(2):318-27. PubMed ID: 20626003
[TBL] [Abstract][Full Text] [Related]
16. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
[TBL] [Abstract][Full Text] [Related]
17. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rd attenuates breast cancer metastasis implicating derepressing microRNA-18a-regulated Smad2 expression.
Wang P; Du X; Xiong M; Cui J; Yang Q; Wang W; Chen Y; Zhang T
Sci Rep; 2016 Sep; 6():33709. PubMed ID: 27641158
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
[TBL] [Abstract][Full Text] [Related]
20. miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer.
Zhang W; Li Y
Int J Oncol; 2016 May; 48(5):1877-85. PubMed ID: 26983401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]